CXCL5 secreted by inflammatory lymphatic endothelial cells promotes migration, invasion, and metabolic reprogramming in cholangiocarcinoma, which further enhance the metastasis of cholangiocarcinoma (32). This evidence concerns the gene CXCL5 and cholangiocarcinoma.